Survival Following Percutaneous Endoscopic Gastrostomy in Neurology Intensive Care Unit Patients

Öz

Background: We aimed to determine factors affecting mortality and survival after Percutaneous endoscopic gastrostomy (PEG) in patients who were hospitalized in the neurology intensive care unit during the coronavirus disease-2019 (COVID-19) pandemic Materials and Methods: The clinical and demographic data of 29 patients aged 18 years and older who received PEG tube insertion during hospitalization in the Neurology Intensive Care Unit of XXX Hospital, Turkey, between February 2020 and May 2021 were examined retrospectively. Patients’ demographics, clinical characteristics, and survival status were recorded. Results: We included 29 patients (16 females and 13 males) into our study. Median age was 71 (33–89) years among survivors and 75.5 (48–90) years among those who died. The groups were similar with respect to age (p = 0.119) and sex (p = 0.806). Mortality rate after PEG insertion was 66%. Mean overall survival after PEG tube insertion was 129.49 days (95% CI: 91.21–167.78). Cox regression revealed that having multiple comorbidities increased the likelihood of mortality by 2.822-fold (95% CI: 1.001–7.968, p = 0.049). Conclusions: These findings show that having multiple comorbidities was the most important factor associated with mortality among PEG recipients who were admitted to the Neurology Intensive Care Unit during the COVID-19 pandemic. Since multiple comorbidities cause shorter survival, it appears that the decision to insert PEG tubes must be made extremely cautiously among these patients. However, more comprehensive studies should be conducted to clarify the effect of COVID-19 on mortality rates and survival time after PEG.

Anahtar Kelimeler

• percutaneous endoscopic gastrostomy
• COVID-19 pandemic
• comorbidity
• mortality
• survival

Nöroloji Yoğun Bakım Ünitesindeki Hastalarda Perkütan Endoskopik Gastrostomi Sonrası Sağkalım

Öz

Amaç: Koronavirüs hastalığı-2019 (COVID-19) pandemisi sırasında nöroloji yoğun bakım ünitesinde yatan has-talarda Perkütan endoskopik gastrostomi (PEG) sonrası mortalite ve sağkalımı etkileyen faktörleri belirlemeyi amaçladık. Materyal ve Metod: Türkiye'de Bursa Şehir Hastanesi Nöroloji Yoğun Bakım Ünitesinde Şubat 2020 ile Mayıs 2021 tarihleri arasında yatışı sırasında PEG tüpü takılan 18 yaş ve üzeri 29 hastanın klinik ve demografik verileri geriye dönük olarak incelendi. Hastaların demografik özellikleri, klinik özellikleri ve sağkalım durumları kaydedildi. Bulgular: Çalışmamıza 29 hasta (16 kadın ve 13 erkek) dahil edildi. Ortanca yaş hayatta kalanlar arasında 71 (33-89) ve ölenler arasında 75,5 (48-90) idi. Gruplar yaş (p = 0.119) ve cinsiyet (p = 0.806) açısından benzerdi. PEG yerleştirilmesinden sonra ölüm oranı %66 idi. PEG tüpünün yerleştirilmesinden sonra ortalama genel sağkalım 129.49 gündü (%95 GA: 91.21–167.78). Cox regresyonu, birden fazla komorbiditeye sahip olmanın mortalite olasılığını 2.822 kat arttırdığını ortaya koydu (%95 GA: 1.001-7.968, p = 0.049). Sonuç: Bu bulgular, COVID-19 pandemisi sırasında Nöroloji Yoğun Bakım Ünitesi’ne kabul edilen ve PEG tüpü takılan olgularda mortalite ile ilişkili en önemli faktörün birden fazla komorbiditeye sahip olması olduğunu gös-termektedir. Çoklu komorbiditeler daha kısa sağ kalıma neden olduğundan, bu hastalarda PEG tüpü yerleştirme kararının son derece dikkatli verilmesi gerektiği görülmektedir. Ancak COVID-19'un PEG sonrası ölüm oranları ve sağkalım süresi üzerindeki etkisini netleştirmek için daha kapsamlı çalışmalar yapılmalıdır.

Anahtar Kelimeler

• perkütan endoskopik gastrostomi
• COVID-19 pandemisi
• komorbidite
• mortalite
• sağkalım

Kaynakça

1. 1. Jung SH, Dong SH, Lee JY, Kim NH, Jang JY, Kim HJ, et al. Percutaneous Endoscopic Gastrostomy Prevents Gastroesophageal Reflux in Patients with Nasogastric Tube Feeding: A Prospective Study with 24-Hour pH Monitoring. Gut Liver. 2011; 5(3):288-92.
2. 2. Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, Kurtz A, Farkas DT. Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol. 2014; 20(24):7739-51.
3. 3. Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer. 2001; 91(9):1785-90.
4. 4. Park RH, Allison MC, Lang J, Spence E, Morris AJ, Danesh BJ, et al. Randomised comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with persisting neurological dysphagia. BMJ. 1992; 304(6839):1406-9.
5. 5. Goyal H, Perisetti A, Tharian B. Percutaneous Endoscopic Gastrostomy tube placement in COVID-19 patients: Multidisciplinary approach. Dig Endosc. 2021; 33(1):209.
6. 6. Friginal-Ruiz AB, Lucendo AJ. Percutaneous Endoscopic Gastrostomy: A Practical Overview on Its Indications, Placement Conditions, Management, and Nursing Care. Gastroenterol Nurs. 2015; 38(5):354-66; quiz 67-8.
7. 7. Bommena S, Rangan P, Lee-Iannotti J, Nanda R. S618 Timing and Outcomes of Percutaneous Endoscopic Gastrostomy After Ischemic Stroke. Am J Gastroenterol. 2021; 116:S280-S1.
8. 8. Yarmus L, Gilbert C, Lechtzin N, Imad M, Ernst A, Feller-Kopman D. Safety and feasibility of interventional pulmonologists performing bedside percutaneous endoscopic gastrostomy tube placement. Chest. 2013; 144(2):436-40.

9. 9. Reddy KM, Lee P, Gor P, Al-Hammadi N, Westrich D, Taylor J. S0553 Early vs late percutaneous endoscopic gastrostomy (peg) tube placement in post-stroke patients: mortality, predictors of mortality, complications, and outcomes. Am J Gastroenterol. 2020; 115:S259.
10. 10. Light VL, Slezak FA, Porter JA, Gerson LW, Mccord G. Predictive factors for early mortality after percutaneous endoscopic gastrostomy. Gastrointest Endosc. 1995; 42(4):330-5.
11. 11. Sacks BA, Vine HS, Palestrant AM, Ellison HP, Shropshire D, Lowe R. A nonoperative technique for establishment of a gastrostomy in the dog. Invest Radiol. 1983; 18(5):485-7.
12. 12. Lie I, Stafseth S, Skogstad L, Hovland IS, Hovde H, Ekeberg Ø, et al. Healthcare professionals in COVID-19-intensive care units in Norway: preparedness and working conditions: a cohort study. BMJ Open. 2021; 11(10):e049135.
13. 13. Silistre ES, Hatipoğlu HU, Yeşilbaş O, Gürbüz FŞ, Ozturk E, Yalcinkaya A. Investigating the psychological impact of COVID-19 on healthcare workers in the intensive care unit. J Surg Med. 2022; 6(1):29-35.
14. 14. Ben Hassine D, Zemni I, Dhouib W, Ben Fredj M, Bennasrallah C, Kacem M, et al. Health system saturation in managing COVID-19 patients in Monastir, Tunisia. Eur J Public Health. 2021; 31(Supplement_3):ckab165. 01.
15. 15. Cividjian A, Wallet F, Guichon C, Martin O, Couray-Targe S, Rimmelé T, et al. Simplified model of the number of Covid-19 patients in the ICU: update April 6, 2020. medRxiv. 2020.
16. 16. Kj Adhikari N, Beane A, Devaprasad D, Fowler R, Haniffa R, James A, et al. Impact of COVID-19 on non-COVID intensive care unit service utilization, case mix and outcomes: A registry-based analysis from India. Wellcome Open Res. 2021; 6:159.
17. 17. Bologheanu R, Maleczek M, Laxar D, Kimberger O. Outcomes of non-COVID-19 critically ill patients during the COVID-19 pandemic : A retrospective propensity score-matched analysis. Wien Klin Wochenschr. 2021; 133(17-18):942-50.
18. 18. Anderson MA, Ben-Menachem T, Gan SI, Appalaneni V, Banerjee S, Cash BD, et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc. 2009; 70(6):1060-70.
19. 19. Liu X, Yang Z, He S, Wang G. Percutaneous endoscopic gastrostomy. Int J Gastrointest Interv. 2021; 10(2):42-8.
20. 20. Saka B, Zirtil C, Erten SN, Akpinar TS, Altinkaynak M, Akyuz F, et al. Indications, effectiveness and safety of percutaneous endoscopic gastrostomy: A single center experience and literature review. Asia Pac J Clin Nutr. 2021; 30(1):42-50.
21. 21. Gundogan K, Yurci A, Coskun R, Baskol M, Gursoy S, Hebbar G, et al. Outcomes of percutaneous endoscopic gastrostomy in hospitalized patients at a tertiary care center in Turkey. Eur J Clin Nutr. 2014; 68(4):437-40.
22. 22. Schneider AS, Schettler A, Markowski A, Luettig B, Kaufmann B, Klamt S, et al. Complication and mortality rate after percutaneous endoscopic gastrostomy are low and indication-dependent. Scand J Gastroenterol. 2014; 49(7):891-8.
23. 23. Adachi Y, Akino K, Nojima M, Himori R, Kikuchi T, Mita H, et al. Prognostic nutritional index and early mortality with percutaneous endoscopic gastrostomy. QJM. 2018; 111(9):635-41.
24. 24. Arora G, Rockey D, Gupta S. High In-hospital mortality after percutaneous endoscopic gastrostomy: results of a nationwide population-based study. Clin Gastroenterol Hepatol. 2013; 11(11):1437-44.e3.
25. 25. Grant DG, Bradley PT, Pothier DD, Bailey D, Caldera S, Baldwin DL, et al. Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and meta-analysis. Clin Otolaryngol. 2009; 34(2):103-12.
26. 26. Murphy LM, Lipman TO. Percutaneous endoscopic gastrostomy does not prolong survival in patients with dementia. Arch Intern Med. 2003; 163(11):1351-3.
27. 27. Blomberg J, Lagergren J, Martin L, Mattsson F, Lagergren P. Complications after percutaneous endoscopic gastrostomy in a prospective study. Scand J Gastroenterol. 2012; 47(6):737-42.
28. 28. Rimon E, Kagansky N, Levy S. Percutaneous endoscopic gastrostomy; evidence of different prognosis in various patient subgroups. Age Ageing. 2005; 34(4):353-7.
29. 29. Blomberg J, Lagergren P, Martin L, Mattsson F, Lagergren J. Albumin and C-reactive protein levels predict short-term mortality after percutaneous endoscopic gastrostomy in a prospective cohort study. Gastrointest Endosc. 2011; 73(1):29-36.
30. 30. Ota K, Takeuchi T, Masuda D, Sanomura M, Kojima K, Nakanishi Y, et al. Risk factors for postoperative bleeding and early death in percutaneous endoscopic gastrostomy: A multicenter retrospective study. J Gastroenterol Hepatol. 2022; 37(1):97-103.
31. 31. Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med. 2020; 46(5):837-40.
32. 32. Goh KJ, Wong J, Tien JC, Ng SY, Duu Wen S, Phua GC, et al. Preparing your intensive care unit for the COVID-19 pandemic: practical considerations and strategies. Crit Care. 2020; 24(1):215.
33. 33. Padua L, Fredda G, Coraci D, Reale G, Glorioso D, Loreti C, et al. COVID-19 and hospital restrictions: physical disconnection and digital re-connection in disorders of consciousness. Brain Inj. 2021; 35(10):1134-42.